{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:05:46Z","timestamp":1766048746244},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.5414\/cp202772","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T15:07:19Z","timestamp":1479913639000},"page":"119-125","source":"Crossref","is-referenced-by-count":7,"title":["Treatment persistence in the use of basal insulins in Poland and Germany"],"prefix":"10.5414","volume":"55","author":[{"given":"Wolfgang","family":"Rathmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Czech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Franek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T14:53:57Z","timestamp":1484924037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=14959&doi=10.5414\/CP202772&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":0,"journal-issue":{"issue":"02","published-print":{"date-parts":[[2017]]}},"alternative-id":["202772"],"URL":"https:\/\/doi.org\/10.5414\/cp202772","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}